ABT logo

Abbott Laboratories (ABT) Free Cash Flow

Annual FCF

$5.06 B
-$2.75 B-35.17%

31 December 2023

ABT Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly FCF

$2.15 B
+$722.00 M+50.60%

30 September 2024

ABT Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM FCF

$6.49 B
+$832.00 M+14.72%

30 September 2024

ABT TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABT Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-35.2%+63.2%+44.4%
3 y3 years-11.6%-4.1%-30.4%
5 y5 years+3.1%+38.9%+70.1%

ABT Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-41.5%at low-12.4%+242.7%-30.4%+44.4%
5 y5 years-41.5%+12.5%-31.1%+505.4%-30.4%+70.1%
alltimeall time-41.5%+1225.7%-31.1%+671.6%-30.4%>+9999.0%

Abbott Laboratories Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
$2.15 B(+50.6%)
$6.49 B(+14.7%)
June 2024
-
$1.43 B(+127.6%)
$5.65 B(+14.8%)
Mar 2024
-
$627.00 M(-72.5%)
$4.92 B(-2.7%)
Dec 2023
$5.06 B(-35.2%)
$2.28 B(+73.3%)
$5.06 B(+12.6%)
Sept 2023
-
$1.32 B(+89.2%)
$4.49 B(-18.1%)
June 2023
-
$696.00 M(-8.8%)
$5.49 B(-19.6%)
Mar 2023
-
$763.00 M(-55.5%)
$6.82 B(-12.6%)
Dec 2022
$7.80 B(-9.8%)
$1.72 B(-25.8%)
$7.80 B(-8.6%)
Sept 2022
-
$2.31 B(+13.9%)
$8.54 B(+0.9%)
June 2022
-
$2.03 B(+16.5%)
$8.47 B(+3.9%)
Mar 2022
-
$1.74 B(-28.9%)
$8.15 B(-5.7%)
Dec 2021
$8.65 B(+51.1%)
$2.45 B(+9.5%)
$8.65 B(-7.2%)
Sept 2021
-
$2.24 B(+30.6%)
$9.31 B(+7.8%)
June 2021
-
$1.72 B(-23.4%)
$8.64 B(+13.6%)
Mar 2021
-
$2.24 B(-28.2%)
$7.61 B(+32.9%)
Dec 2020
$5.72 B(+27.3%)
$3.12 B(+98.7%)
$5.72 B(+24.8%)
Sept 2020
-
$1.57 B(+130.9%)
$4.59 B(+0.5%)
June 2020
-
$680.00 M(+91.5%)
$4.56 B(+2.0%)
Mar 2020
-
$355.00 M(-82.1%)
$4.48 B(-0.5%)
Dec 2019
$4.50 B(-8.3%)
$1.98 B(+28.1%)
$4.50 B(+17.9%)
Sept 2019
-
$1.55 B(+161.3%)
$3.81 B(-6.9%)
June 2019
-
$592.00 M(+57.0%)
$4.10 B(-8.0%)
Mar 2019
-
$377.00 M(-71.0%)
$4.45 B(-9.3%)
Dec 2018
$4.91 B(+10.6%)
$1.30 B(-29.0%)
$4.91 B(+0.1%)
Sept 2018
-
$1.83 B(+93.3%)
$4.90 B(+1.8%)
June 2018
-
$946.00 M(+13.6%)
$4.82 B(-3.0%)
Mar 2018
-
$833.00 M(-35.7%)
$4.97 B(+12.0%)
Dec 2017
$4.43 B(+113.0%)
$1.29 B(-25.7%)
$4.43 B(+11.1%)
Sept 2017
-
$1.74 B(+58.9%)
$3.99 B(+26.5%)
June 2017
-
$1.10 B(+262.9%)
$3.15 B(+16.0%)
Mar 2017
-
$302.00 M(-64.5%)
$2.72 B(+30.6%)
Dec 2016
$2.08 B(+12.2%)
$851.00 M(-6.0%)
$2.08 B(+15.0%)
Sept 2016
-
$905.00 M(+36.7%)
$1.81 B(+7.2%)
June 2016
-
$662.00 M(-297.0%)
$1.69 B(-3.6%)
Mar 2016
-
-$336.00 M(-157.9%)
$1.75 B(-5.5%)
Dec 2015
$1.86 B(-28.6%)
$580.00 M(-26.0%)
$1.86 B(-16.7%)
Sept 2015
-
$784.00 M(+8.1%)
$2.23 B(-5.9%)
June 2015
-
$725.00 M(-411.2%)
$2.37 B(+3.6%)
Mar 2015
-
-$233.00 M(-124.5%)
$2.28 B(-12.1%)
Dec 2014
$2.60 B(+19.2%)
$951.00 M(+2.9%)
$2.60 B(-12.5%)
Sept 2014
-
$924.00 M(+43.9%)
$2.97 B(+29.7%)
June 2014
-
$642.00 M(+692.6%)
$2.29 B(+10.4%)
Mar 2014
-
$81.00 M(-93.9%)
$2.07 B(-4.8%)
Dec 2013
$2.18 B(-71.0%)
$1.32 B(+439.6%)
$2.18 B(+10.4%)
Sept 2013
-
$245.00 M(-42.5%)
$1.97 B(-58.2%)
June 2013
-
$426.00 M(+129.0%)
$4.72 B(-20.5%)
Mar 2013
-
$186.00 M(-83.3%)
$5.93 B(-21.1%)
Dec 2012
$7.52 B(+0.5%)
$1.12 B(-62.6%)
$7.52 B(-0.1%)
Sept 2012
-
$2.99 B(+82.1%)
$7.53 B(+5.4%)
June 2012
-
$1.64 B(-7.3%)
$7.14 B(-6.4%)
Mar 2012
-
$1.77 B(+57.2%)
$7.63 B(+2.0%)
Dec 2011
$7.48 B(-3.1%)
$1.13 B(-56.7%)
$7.48 B(-10.7%)
Sept 2011
-
$2.60 B(+22.2%)
$8.38 B(+3.2%)
June 2011
-
$2.13 B(+31.5%)
$8.12 B(+0.7%)
Mar 2011
-
$1.62 B(-20.0%)
$8.06 B(+4.4%)
Dec 2010
$7.72 B(+24.8%)
$2.03 B(-13.6%)
$7.72 B(+6.0%)
Sept 2010
-
$2.34 B(+12.9%)
$7.28 B(-4.7%)
June 2010
-
$2.07 B(+62.4%)
$7.64 B(+8.9%)
Mar 2010
-
$1.28 B(-19.5%)
$7.02 B(+13.4%)
Dec 2009
$6.19 B(+8.4%)
$1.59 B(-41.2%)
$6.19 B(+11.1%)
Sept 2009
-
$2.70 B(+86.2%)
$5.57 B(+6.2%)
June 2009
-
$1.45 B(+224.9%)
$5.24 B(+1.2%)
Mar 2009
-
$446.57 M(-53.9%)
$5.18 B(-9.2%)
Dec 2008
$5.71 B(+61.8%)
$967.99 M(-59.3%)
$5.71 B(+6.5%)
Sept 2008
-
$2.38 B(+71.4%)
$5.36 B(+29.7%)
June 2008
-
$1.39 B(+42.8%)
$4.13 B(+9.5%)
Mar 2008
-
$972.17 M(+56.5%)
$3.77 B(+6.9%)
Dec 2007
$3.53 B
$621.31 M(-46.0%)
$3.53 B(-9.1%)
Sept 2007
-
$1.15 B(+11.8%)
$3.88 B(+5.9%)
June 2007
-
$1.03 B(+41.5%)
$3.66 B(-4.4%)
DateAnnualQuarterlyTTM
Mar 2007
-
$727.17 M(-25.4%)
$3.83 B(-4.0%)
Dec 2006
$3.99 B(+0.6%)
$974.42 M(+4.5%)
$3.99 B(-1.6%)
Sept 2006
-
$932.55 M(-22.1%)
$4.06 B(-5.4%)
June 2006
-
$1.20 B(+35.0%)
$4.29 B(-7.9%)
Mar 2006
-
$886.87 M(-14.7%)
$4.65 B(+17.3%)
Dec 2005
$3.97 B(+24.9%)
$1.04 B(-10.6%)
$3.97 B(+15.6%)
Sept 2005
-
$1.16 B(-25.7%)
$3.43 B(+24.2%)
June 2005
-
$1.56 B(+684.0%)
$2.76 B(+15.9%)
Mar 2005
-
$199.58 M(-60.4%)
$2.38 B(-24.9%)
Dec 2004
$3.18 B(+26.9%)
$503.77 M(+2.0%)
$3.18 B(+5.6%)
Sept 2004
-
$493.86 M(-58.4%)
$3.01 B(-7.9%)
June 2004
-
$1.19 B(+19.6%)
$3.26 B(+15.1%)
Mar 2004
-
$991.75 M(+194.8%)
$2.84 B(+13.3%)
Dec 2003
$2.50 B(-13.3%)
$336.44 M(-55.2%)
$2.50 B(-16.0%)
Sept 2003
-
$750.62 M(-1.0%)
$2.98 B(+5.6%)
June 2003
-
$757.88 M(+15.2%)
$2.82 B(+4.2%)
Mar 2003
-
$658.10 M(-19.1%)
$2.71 B(-6.3%)
Dec 2002
$2.89 B(+20.1%)
$813.33 M(+37.5%)
$2.89 B(+11.1%)
Sept 2002
-
$591.32 M(-8.1%)
$2.60 B(-6.6%)
June 2002
-
$643.29 M(-23.3%)
$2.78 B(+8.6%)
Mar 2002
-
$838.70 M(+59.7%)
$2.56 B(+6.5%)
Dec 2001
$2.40 B(+16.4%)
$525.29 M(-32.1%)
$2.40 B(+2.5%)
Sept 2001
-
$774.16 M(+83.5%)
$2.34 B(+14.3%)
June 2001
-
$421.90 M(-38.1%)
$2.05 B(-21.3%)
Mar 2001
-
$681.79 M(+46.1%)
$2.61 B(+26.3%)
Dec 2000
$2.06 B(+19.1%)
$466.55 M(-2.9%)
$2.06 B(+42.2%)
Sept 2000
-
$480.48 M(-50.9%)
$1.45 B(-14.7%)
June 2000
-
$978.55 M(+608.3%)
$1.70 B(+34.7%)
Mar 2000
-
$138.16 M(-195.0%)
$1.26 B(-27.1%)
Dec 1999
$1.73 B(+12.7%)
-$145.42 M(-119.9%)
$1.73 B(-17.2%)
Sept 1999
-
$730.82 M(+35.4%)
$2.09 B(+112.0%)
June 1999
-
$539.77 M(-11.3%)
$987.86 M(-34.3%)
Mar 1999
-
$608.23 M(+181.8%)
$1.50 B(-2.3%)
Dec 1998
$1.54 B(+6.0%)
$215.80 M(-157.4%)
$1.54 B(+2.9%)
Sept 1998
-
-$375.94 M(-135.6%)
$1.49 B(-16.2%)
June 1998
-
$1.05 B(+64.0%)
$1.78 B(+36.3%)
Mar 1998
-
$643.00 M(+272.3%)
$1.31 B(-9.8%)
Dec 1997
$1.45 B(+1.2%)
$172.70 M(-300.6%)
$1.45 B(-8.3%)
Sept 1997
-
-$86.11 M(-114.9%)
$1.58 B(-24.0%)
June 1997
-
$579.28 M(-26.2%)
$2.08 B(+17.9%)
Mar 1997
-
$784.63 M(+158.8%)
$1.76 B(+23.0%)
Dec 1996
$1.43 B(-27.1%)
$303.13 M(-26.4%)
$1.43 B(-7.0%)
Sept 1996
-
$411.87 M(+56.2%)
$1.54 B(-6.5%)
June 1996
-
$263.70 M(-42.0%)
$1.65 B(-13.8%)
Mar 1996
-
$454.40 M(+10.5%)
$1.91 B(-2.7%)
Dec 1995
$1.97 B(-11.1%)
$411.18 M(-20.8%)
$1.97 B(-8.4%)
Sept 1995
-
$519.18 M(-1.5%)
$2.15 B(-3.6%)
June 1995
-
$526.89 M(+3.7%)
$2.23 B(+2.5%)
Mar 1995
-
$508.33 M(-14.1%)
$2.17 B(-1.7%)
Dec 1994
$2.21 B(+19.8%)
$591.69 M(-1.5%)
$2.21 B(-20.7%)
Sept 1994
-
$600.46 M(+26.9%)
$2.79 B(+10.8%)
June 1994
-
$473.14 M(-13.5%)
$2.52 B(+16.0%)
Mar 1994
-
$546.85 M(-53.2%)
$2.17 B(+17.5%)
Dec 1993
$1.85 B(+384.0%)
$1.17 B(+255.8%)
$1.85 B(+109.7%)
Sept 1993
-
$328.60 M(+162.9%)
$880.80 M(+54.3%)
June 1993
-
$125.00 M(-44.2%)
$571.00 M(+3.0%)
Mar 1993
-
$224.20 M(+10.4%)
$554.30 M(+45.3%)
Dec 1992
$381.60 M(-44.1%)
$203.00 M(+979.8%)
$381.60 M(+18.5%)
Sept 1992
-
$18.80 M(-82.6%)
$322.00 M(-39.2%)
June 1992
-
$108.30 M(+110.3%)
$530.00 M(-17.6%)
Mar 1992
-
$51.50 M(-64.1%)
$643.10 M(-5.8%)
Dec 1991
$682.60 M(+22.0%)
$143.40 M(-36.8%)
$682.60 M(-6.4%)
Sept 1991
-
$226.80 M(+2.4%)
$729.00 M(+1.5%)
June 1991
-
$221.40 M(+143.3%)
$718.50 M(+22.3%)
Mar 1991
-
$91.00 M(-52.1%)
$587.70 M(+5.0%)
Dec 1990
$559.50 M(+44.6%)
$189.80 M(-12.3%)
$559.50 M(+51.3%)
Sept 1990
-
$216.30 M(+138.7%)
$369.70 M(+141.0%)
June 1990
-
$90.60 M(+44.3%)
$153.40 M(+144.3%)
Mar 1990
-
$62.80 M
$62.80 M
Dec 1989
$386.80 M
-
-

FAQ

  • What is Abbott Laboratories annual free cash flow?
  • What is the all time high annual FCF for Abbott Laboratories?
  • What is Abbott Laboratories annual FCF year-on-year change?
  • What is Abbott Laboratories quarterly free cash flow?
  • What is the all time high quarterly FCF for Abbott Laboratories?
  • What is Abbott Laboratories quarterly FCF year-on-year change?
  • What is Abbott Laboratories TTM free cash flow?
  • What is the all time high TTM FCF for Abbott Laboratories?
  • What is Abbott Laboratories TTM FCF year-on-year change?

What is Abbott Laboratories annual free cash flow?

The current annual FCF of ABT is $5.06 B

What is the all time high annual FCF for Abbott Laboratories?

Abbott Laboratories all-time high annual free cash flow is $8.65 B

What is Abbott Laboratories annual FCF year-on-year change?

Over the past year, ABT annual free cash flow has changed by -$2.75 B (-35.17%)

What is Abbott Laboratories quarterly free cash flow?

The current quarterly FCF of ABT is $2.15 B

What is the all time high quarterly FCF for Abbott Laboratories?

Abbott Laboratories all-time high quarterly free cash flow is $3.12 B

What is Abbott Laboratories quarterly FCF year-on-year change?

Over the past year, ABT quarterly free cash flow has changed by +$832.00 M (+63.17%)

What is Abbott Laboratories TTM free cash flow?

The current TTM FCF of ABT is $6.49 B

What is the all time high TTM FCF for Abbott Laboratories?

Abbott Laboratories all-time high TTM free cash flow is $9.31 B

What is Abbott Laboratories TTM FCF year-on-year change?

Over the past year, ABT TTM free cash flow has changed by +$1.99 B (+44.39%)